Global Patent Index - EP 4108687 A1

EP 4108687 A1 20221228 - RECOMBINANT RSV ANTIGENS

Title (en)

RECOMBINANT RSV ANTIGENS

Title (de)

REKOMBINANTE RSV-ANTIGENE

Title (fr)

ANTIGÈNES RECOMBINANTS DU RSV

Publication

EP 4108687 A1 20221228 (EN)

Application

EP 22181398 A 20081223

Priority

  • US 1652407 P 20071224
  • US 5620608 P 20080527
  • EP 19152924 A 20081223
  • EP 16180926 A 20081223
  • EP 08864495 A 20081223
  • CA 2008002277 W 20081223

Abstract (en)

This disclosure provides recombinant respiratory syncytial virus (RSV) antigens and methods for making and using them, including immunogenic compositions (e.g., vaccines) for the treatment and/or prevention of RSV infection.

IPC 8 full level

C07K 19/00 (2006.01); A61K 9/107 (2006.01); A61K 9/127 (2006.01); A61K 39/00 (2006.01); A61K 39/12 (2006.01); A61K 39/155 (2006.01); A61K 39/295 (2006.01); A61P 31/14 (2006.01); A61P 37/04 (2006.01); C07K 14/005 (2006.01); C07K 14/135 (2006.01); C12N 15/45 (2006.01); C12N 15/62 (2006.01)

CPC (source: EP US)

A61K 39/12 (2013.01 - EP US); A61K 39/155 (2013.01 - EP US); A61P 31/00 (2018.01 - EP); A61P 31/12 (2018.01 - EP); A61P 31/14 (2018.01 - EP); A61P 37/00 (2018.01 - EP); A61P 37/04 (2018.01 - EP); C07K 14/005 (2013.01 - EP US); C07K 16/1027 (2013.01 - EP US); A61K 2039/55505 (2013.01 - EP US); A61K 2039/55572 (2013.01 - EP US); A61K 2039/55577 (2013.01 - EP US); C07K 2317/21 (2013.01 - EP US); C07K 2317/76 (2013.01 - EP US); C07K 2319/73 (2013.01 - EP US); C12N 2760/18522 (2013.01 - EP US); C12N 2760/18534 (2013.01 - EP US); Y02A 50/30 (2018.01 - EP US)

Citation (applicant)

Citation (search report)

  • [A] WO 2006042156 A2 20060420 - US GOV HEALTH & HUMAN SERV [US], et al
  • [AP] WO 2008154456 A2 20081218 - NATIONWIDE CHILDRENS HOSPITAL [US], et al
  • [E] WO 2018176103 A1 20181004 - UNIV QUEENSLAND [AU]
  • [A] DIANA MART N ET AL: "Sequence elements of the fusion peptide of human respiratory syncytial virus fusion protein required for activity", JOURNAL OF GENERAL VIROLOGY, SOCIETY FOR GENERAL MICROBIOLOGY, SPENCERS WOOD, GB, vol. 87, 2006, pages 1649 - 1658, XP002600413, ISSN: 0022-1317, DOI: 10.1099/VIR.0.81715-0
  • [A] LUIS GONZÁLEZ-REYES ET AL: "Cleavage of the human respiratory syncytial virus fusion protein at two distinct sites is required for activation of membrane fusion", PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES, NATIONAL ACADEMY OF SCIENCES, US, vol. 98, no. 17, 14 August 2001 (2001-08-14), pages 9859 - 9864, XP008136810, ISSN: 0027-8424, DOI: 10.1073/PNAS.151098198
  • [A] SASTRE PATRICIA ET AL: "Comparison of affinity chromatography and adsorption to vaccinia virus recombinant infected cells for depletion of antibodies directed against respiratory syncytial virus glycoproteins present in a human immunoglobulin preparation", JOURNAL OF MEDICAL VIROLOGY, JOHN WILEY & SONS, INC, US, vol. 76, no. 2, 1 June 2005 (2005-06-01), pages 248 - 255, XP002444395, ISSN: 0146-6615, DOI: 10.1002/JMV.20349
  • [A] SINGH ET AL: "Immunogenicity and efficacy of recombinant RSV-F vaccine in a mouse model", VACCINE, ELSEVIER LTD, GB, vol. 25, no. 33, 24 July 2007 (2007-07-24), pages 6211 - 6223, XP022168621, ISSN: 0264-410X, DOI: 10.1016/J.VACCINE.2007.05.068
  • [A] VAN DRUNEN LITTEL-VAN DEN HURK S ET AL: "Immunopathology of RSV infection: prospects for developing vaccines without this complication", REVIEWS IN MEDICAL VIROLOGY, CHICHESTER, GB, vol. 17, no. 1, 27 September 2007 (2007-09-27), pages 5 - 34, XP002510797, ISSN: 1052-9276, [retrieved on 20060927], DOI: 10.1002/RMV.518
  • [T] M. MAGRO ET AL: "Neutralizing antibodies against the preactive form of respiratory syncytial virus fusion protein offer unique possibilities for clinical intervention", PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES, vol. 109, no. 8, 21 February 2012 (2012-02-21), pages 3089 - 3094, XP055067859, ISSN: 0027-8424, DOI: 10.1073/pnas.1115941109
  • [T] ALAN RIGTER ET AL: "A Protective and Safe Intranasal RSV Vaccine Based on a Recombinant Prefusion-Like Form of the F Protein Bound to Bacterium-Like Particles", 1 August 2013 (2013-08-01), pages e41072.1, XP002718926, ISSN: 1932-6203, Retrieved from the Internet <URL:http://www.plosone.org/article/fetchObject.action?uri=info%3Adoi%2F10.1371%2Fjournal.pone.0071072&representation=PDF> [retrieved on 20130812], DOI: 10.1371/JOURNAL.PONE.0071072
  • [T] J. S. MCLELLAN ET AL: "Structure of RSV Fusion Glycoprotein Trimer Bound to a Prefusion-Specific Neutralizing Antibody", SCIENCE, vol. 340, no. 6136, 25 April 2013 (2013-04-25), pages 1113 - 1117, XP055132644, ISSN: 0036-8075, DOI: 10.1126/science.1234914
  • [T] NORMAND BLAIS ET AL: "Characterization of Pre-F-GCN4t, a Modified Human Respiratory Syncytial Virus Fusion Protein Stabilized in a Noncleaved Prefusion Conformation", JOURNAL OF VIROLOGY, vol. 91, no. 13, 12 April 2017 (2017-04-12), US, pages 1 - 18, XP055652858, ISSN: 0022-538X, DOI: 10.1128/JVI.02437-16
  • [T] J. S. MCLELLAN ET AL: "Structure-Based Design of a Fusion Glycoprotein Vaccine for Respiratory Syncytial Virus", SCIENCE, vol. 342, no. 6158, 1 November 2013 (2013-11-01), US, pages 592 - 598, XP055391357, ISSN: 0036-8075, DOI: 10.1126/science.1243283

Citation (third parties)

Third party : PFIZER

Designated contracting state (EPC)

AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MT NL NO PL PT RO SE SI SK TR

DOCDB simple family (publication)

WO 2009079796 A1 20090702; AU 2008340949 A1 20090702; BR PI0821532 A2 20150616; CA 2710600 A1 20090702; CA 2710600 C 20170606; CN 101952321 A 20110119; CN 101952321 B 20160511; CY 1118090 T1 20170628; DK 2222710 T3 20161003; EA 021393 B1 20150630; EA 201070794 A1 20110228; EP 2222710 A1 20100901; EP 2222710 A4 20130123; EP 2222710 B1 20160727; EP 2222710 B8 20161012; EP 3109258 A1 20161228; EP 3109258 B1 20190123; EP 3508505 A1 20190710; EP 4108687 A1 20221228; EP 4108688 A1 20221228; EP 4206231 A1 20230705; EP 4219566 A2 20230802; EP 4219566 A3 20230906; ES 2597439 T3 20170118; ES 2719406 T3 20190710; HR P20161353 T1 20161202; HU E029258 T2 20170228; JP 2011507533 A 20110310; JP 5711972 B2 20150507; KR 101617895 B1 20160503; KR 20100109933 A 20101011; LT 2222710 T 20161212; MX 2010007107 A 20101221; PL 2222710 T3 20170131; PT 2222710 T 20161102; RS 55162 B1 20170131; SG 188813 A1 20130430; SI 2222710 T1 20161130; US 2010291147 A1 20101118; US 8563002 B2 20131022; ZA 201004289 B 20110428

DOCDB simple family (application)

CA 2008002277 W 20081223; AU 2008340949 A 20081223; BR PI0821532 A 20081223; CA 2710600 A 20081223; CN 200880127407 A 20081223; CY 161101010 T 20161011; DK 08864495 T 20081223; EA 201070794 A 20081223; EP 08864495 A 20081223; EP 16180926 A 20081223; EP 19152924 A 20081223; EP 22181398 A 20081223; EP 22181399 A 20081223; EP 22211934 A 20081223; EP 23150323 A 20081223; ES 08864495 T 20081223; ES 16180926 T 20081223; HR P20161353 T 20161017; HU E08864495 A 20081223; JP 2010539977 A 20081223; KR 20107016541 A 20081223; LT 08864495 T 20081223; MX 2010007107 A 20081223; PL 08864495 T 20081223; PT 08864495 T 20081223; RS P20160792 A 20081223; SG 2013014287 A 20081223; SI 200831685 A 20081223; US 81019608 A 20081223; ZA 201004289 A 20100617